N10 Assets LLC Sells 2,459 Shares of Axon Enterprise, Inc $AXON

N10 Assets LLC cut its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 17.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 11,349 shares of the biotechnology company’s stock after selling 2,459 shares during the quarter. Axon Enterprise comprises 1.8% of N10 Assets LLC’s portfolio, making the stock its 23rd largest position. N10 Assets LLC’s holdings in Axon Enterprise were worth $4,795,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. State Street Corp lifted its stake in shares of Axon Enterprise by 5,700.2% in the 2nd quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock valued at $119,724,905,000 after purchasing an additional 209,879,882 shares during the period. Envestnet Asset Management Inc. lifted its stake in Axon Enterprise by 18,050.2% in the second quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after buying an additional 13,127,348 shares during the period. BlackRock Inc. lifted its stake in Axon Enterprise by 4.3% in the second quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company’s stock valued at $4,672,432,000 after buying an additional 345,365 shares during the period. The Manufacturers Life Insurance Company lifted its stake in Axon Enterprise by 8,432.6% in the second quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock valued at $1,983,414,000 after buying an additional 3,496,493 shares during the period. Finally, Nykredit A S bought a new position in Axon Enterprise during the second quarter worth about $698,937,000. 79.08% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, President Joshua Isner sold 16,775 shares of the stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the sale, the president directly owned 296,974 shares of the company’s stock, valued at approximately $170,590,774.82. This represents a 5.35% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $480.45, for a total transaction of $488,617.65. Following the sale, the insider owned 56,264 shares in the company, valued at $27,032,038.80. This trade represents a 1.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 47,397 shares of company stock valued at $26,722,984 in the last quarter. 4.20% of the stock is owned by company insiders.

Axon Enterprise Trading Down 2.5%

AXON stock traded down $10.24 during midday trading on Wednesday, hitting $403.11. 379,333 shares of the company’s stock were exchanged, compared to its average volume of 1,047,241. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $764.02. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. The company has a market cap of $32.75 billion, a PE ratio of 167.16, a price-to-earnings-growth ratio of 7.80 and a beta of 1.44. The stock’s fifty day moving average price is $511.34 and its 200-day moving average price is $475.41.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.04. The company had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The company’s revenue for the quarter was up 35.3% compared to the same quarter last year. During the same period in the prior year, the company earned $2.12 earnings per share. Research analysts predict that Axon Enterprise, Inc will post 2.12 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on AXON shares. Citigroup reaffirmed a “market outperform” rating on shares of Axon Enterprise in a research note on Thursday, September 17th. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Barclays boosted their price objective on shares of Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Piper Sandler boosted their price objective on shares of Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Finally, UBS Group upped their target price on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $721.57.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.

The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.

Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.